Company / Working Capital per Share
Lineage Cell Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.22
FY2025
5-year range
$0.12 / $0.42
FY2021-FY2025
Trend
+2.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 10 years, ranging from $0.12 in FY2023 to $0.42 in FY2021.
Based on SEC 10-K filings.
0.22 in FY2025 with a 5-year CAGR of -2.2%.
Improved from $0.12 to $0.22 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -3.6%
- 5-Year CAGR
- -2.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share increased 2.5% year-over-year.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.22 | +2.5% |
| FY2024 | $0.21 | +75.7% |
| FY2023 | $0.12 | -50.3% |
| FY2022 | $0.24 | -42.5% |
| FY2021 | $0.42 | +74.0% |
| FY2020 | $0.24 | -39.7% |
| FY2019 | $0.40 | +72.3% |
| FY2018 | $0.23 | -33.0% |
| FY2017 | $0.35 | +87.2% |
| FY2016 | $0.19 | -58.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026